Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.

× No keyword cloud information.

45 in total

1. A new point mutation (P157S) in the reverse transcriptase of human immunodeficiency virus type 1 confers low-level resistance to (-)-beta-2',3'-dideoxy-3'-thiacytidine.

Authors: R A Smith; G J Klarmann; K M Stray; U K von Schwedler; R F Schinazi; B D Preston; T W North
Journal: Antimicrob Agents Chemother Date: 1999-08 Impact factor: 5.191

2. A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

Authors: Robert W Shafer; Kathryn Dupnik; Mark A Winters; Susan H Eshleman
Journal: HIV Seq Compend Date: 2001

3. HIV-1 reverse transcriptase (RT) polymorphism 172K suppresses the effect of clinically relevant drug resistance mutations to both nucleoside and non-nucleoside RT inhibitors.

Authors: Atsuko Hachiya; Bruno Marchand; Karen A Kirby; Eleftherios Michailidis; Xiongying Tu; Krzysztof Palczewski; Yee Tsuey Ong; Zhe Li; Daniel T Griffin; Matthew M Schuckmann; Junko Tanuma; Shinichi Oka; Kamalendra Singh; Eiichi N Kodama; Stefan G Sarafianos
Journal: J Biol Chem Date: 2012-07-02 Impact factor: 5.157

4. Relative replication fitness of efavirenz-resistant mutants of HIV-1: correlation with frequency during clinical therapy and evidence of compensation for the reduced fitness of K103N + L100I by the nucleoside resistance mutation L74V.

Authors: Christine E Koval; Carrie Dykes; Jiong Wang; Lisa M Demeter
Journal: Virology Date: 2006-06-21 Impact factor: 3.616

5. The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.

Authors: Robert W Shafer; Rami Kantor; Matthew J Gonzales
Journal: AIDS Rev Date: 2000 Impact factor: 2.500

6. Sequence analysis of the polymerase domain of HIV-1 reverse transcriptase in naive and zidovudine-treated individuals reveals a higher polymorphism in alpha-helices as compared with beta-strands.

Authors: L Medrano; L Menéndez-Arias; R De Jorge; M L Villahermosa; G Contreras; L Pérez-Alvarez; A Moya; R Nájera
Journal: Virus Genes Date: 1999 Impact factor: 2.332

7. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase.

Authors: J Goudsmit; A De Ronde; D D Ho; A S Perelson
Journal: J Virol Date: 1996-08 Impact factor: 5.103

8. S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1.

Authors: T Fujiwara; A Sato; M el-Farrash; S Miki; K Abe; Y Isaka; M Kodama; Y Wu; L B Chen; H Harada; H Sugimoto; M Hatanaka; Y Hinuma
Journal: Antimicrob Agents Chemother Date: 1998-06 Impact factor: 5.191

9. Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.

Authors: R E Rose; Y F Gong; J A Greytok; C M Bechtold; B J Terry; B S Robinson; M Alam; R J Colonno; P F Lin
Journal: Proc Natl Acad Sci U S A Date: 1996-02-20 Impact factor: 11.205

10. The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance.

Authors: Antonio J Acosta-Hoyos; Walter A Scott
Journal: Viruses Date: 2010-01-28 Impact factor: 5.048